Kava Kava Hepatotoxicity: Liver Damage & Failure Risks

by

Kava kava, an herbal remedy derived from the roots of Piper methysticum, has long been used in Oceania as a traditional ceremonial drink.

In recent decades it gained popularity in Western countries as an over-the-counter treatment for anxiety, insomnia, and stress.

However, reports of liver damage sparked global restrictions on kava products in the early 2000s. Debate continues over the herb’s potential risks.

Key Facts:

  • Kava originated in the South Pacific islands where it is used to make a traditional, mildly intoxicating drink.
  • Herbal products containing concentrated kava extracts became popular in the 1990s as remedies for anxiety, stress, and sleep issues.
  • By the early 2000s, regulatory agencies received dozens of reports linking kava use to liver injury ranging from enzyme elevations to liver failure requiring transplantation.
  • Numerous countries banned or restricted kava products, but debate continues over causality and the number of affected users.
  • Possible mechanisms for kava hepatotoxicity include product quality issues, interactions with other drugs/herbs, and individual genetic variability.

Source: Liver International & LiverTox

Kava Kava: Herbal Extract for Relaxation

Kava or kava kava refers to both the Piper methysticum plant and drinks or extracts prepared from its roots and rhizomes.

Pacific Islanders have used aqueous kava extracts socially and ceremonially for centuries due to their relaxing, mildly intoxicating effects without impairing mental clarity.

The active ingredients are kavapyrones or kavalactones.

In the 1990s, concentrated kava extracts prepared with acetone or ethanol grew popular in Europe and the United States as over-the-counter remedies for anxiety, insomnia, stress, and other conditions.

Marketers touted kava as a natural alternative to pharmaceuticals like benzodiazepines.

Reports of Liver Damage Linked to Kava Supplements

In 1998, the first case report appeared describing liver problems in a patient taking kava extracts.

Over the next several years, regulatory agencies received dozens more reports of liver damage linked to kava supplements, including several fulminant liver failure cases requiring transplantation.

The roots of the kava controversy emerged in Germany where kava products became immensely popular in the 1990s.

In 2000, the German Federal Institute for Drugs and Medical Devices (BfArM) issued a warning after 15 cases of liver toxicity associated with kava.

Use declined after BfArM’s actions and additional restrictions in Switzerland, France, Canada and other countries.

In 2003, the World Health Organization (WHO) published an assessment of kava safety reviewing over 90 worldwide cases linked to kava use.

The WHO concluded that kava hepatotoxicity was a rare but potential risk. However, kava advocates disputed the strength of this evidence.

Kava Hepatotoxicity: Controversy & Debate

While many countries restricted or withdrew kava products, debate continues between regulators on one side and kava proponents and manufacturers on the other.

Issues under discussion include:

  • Actual number of liver injury cases – Reported cases range from less than 100 to over 200 depending on the source. Kava proponents argue regulators overstate risks given kava’s widespread use. However, adverse event reporting captures only a fraction of cases.
  • Strength of causality assessments – Critics argue that regulators failed to rigorously establish that kava itself caused liver problems rather than co-medicated drugs, herbal adulterants, or pre-existing conditions. However, assessing causality is inherently difficult with limited clinical data.
  • Role of product quality – Variable manufacturing processes and lack of quality control raise concerns about toxicity from non-root ingredients or incorrect plant parts. However, aqueous and solvent-extracted products both linked to liver damage.
  • Mechanism of toxicity – Specific ingredients and biological pathways responsible remain unclear. Proposed mechanisms include glutathione depletion, enzyme inhibition, pyridone accumulation, or idiosyncratic reactions.
See also  Kava Kava: Pacific Roots, Neuropharmacology, Modern Resurgence

These disputes reflect the broader challenge of balancing safety and access with herbal remedies that lack rigorous regulation and clinical testing.

Possible Mechanisms of Kava Hepatotoxicity

The exact biological mechanisms of kava hepatotoxicity are unclear but several possibilities have been proposed:

Product Quality Issues

  • Use of incorrect plant parts – Leaves or aerial stem peelings rather than roots may introduce toxic alkaloids.
  • Contamination – Poor manufacturing processes may risk contamination with hepatotoxins.
  • Overdose – Excessive doses or prolonged usage could produce toxic levels of kavalactones.

Drug Interactions

  • Inhibition of cytochrome P450 enzymes – Kavalactones may increase exposure to co-medications metabolized by these liver enzymes.
  • Enhanced toxicity of metabolites – Kavalactone breakdown may yield hepatotoxic byproducts.
  • Glutathione depletion – Ethanol/acetone extracts lack glutathione present in traditional water extracts.

Individual Susceptibility

  • Genetic variability – Potential differences in metabolism, transporters, or immune response.
  • Idiosyncratic reactions – Some individuals may experience hypersensitivity-like reactions.

Kava Hepatotoxicity: Risk Factors & Safety Recommendations

While additional research is clearly needed, current evidence suggests the following risk factors for kava hepatotoxicity:

  • Product quality – Seek reputable brands using peeled rhizome and root. Avoid non-root ingredients.
  • Co-medication – Check for interactions with prescription drugs, herbs, and supplements.
  • Dosing – Do not exceed label-recommended dosages. Avoid prolonged usage over 3 months.
  • Alcohol – Avoid combining kava and alcohol.
  • Pre-existing liver disease – Use caution with any history of liver problems.
  • Signs of liver injury – Discontinue kava and see a doctor if symptoms like fatigue, nausea, or jaundice develop.

Kava & Liver Problems: Lessons Learned

The kava controversy highlights the broader need for improved safety data and regulation around herbal supplements and natural remedies, which lie in a grey area between foods and drugs.

Kava serves as a case study on how to better evaluate and manage potential risks related to traditional medicines entering widespread use.

Key lessons include:

  • Prioritizing safety – Rigorously investigate early signals of adverse effects through enhanced monitoring and data analysis.
  • Improving manufacturing – Establish quality standards for ingredients, processes, and labeling accuracy.
  • Communicating risks – Alert consumers and healthcare providers early when possible hazards emerge.
  • Advancing the science – Support more clinical safety trials and research on mechanisms of action and toxicity.
  • Balancing access – Restrict products when clear hazards exist, but avoid over-reacting to weak evidence.

While kava’s risks are still debated, its history provides important wisdom that can guide future improvements in herbal medicine safety.

References